Congratulations to CCS 2017 NHMRC grant recipients!

Congratulations to all of our National Health and Medical Research Council (NHMRC) project grant recipients in Central Clinical School (CCS)! In addition to the CCS based recipients listed below, we would also like to congratulate Dr Nadine Andrew who is in the process of transferring her grants to CCS from the School of Clinical Sciences. Nadine is based at Peninsula Health with Velandai Srikanth’s group. We also farewell Professor Magdalena Plebanski, who is taking on a senior role at RMIT of Enabling Capability Platform Director, Health and Biomedical Sciences.

	CDF Name	Grant Title	TOTAL
	Dr Nadine Andrews Peninsula Clinical School	Evaluation of enhanced models of primary care in the management of stroke and other chronic diseases	$556,183
	Dr Dan Andrews Department of Immunology and Pathology	The unique nature of gamma delta T cell recognition resolved through interaction with H2-Q10	$699,031
	Dr Catriona Bradshaw Melbourne Sexual Health Centre	Antibiotic treatment of male partners to reduce recurrence of bacterial vaginosis in women: a randomised double-blind trial	$636,673
	Prof Mark Cooper Department of Diabetes	Targeting epigenetic pathways that lead to diabetic complications	$989,948
	A/Prof Christoph Hagemeyer Australian Centre for Blood Diseases	Degradable nanocapsules for thromboprophylaxis and treatment of acute thrombosis	$1,158,447
	A/Prof Jody Haigh Australian Centre for Blood Diseases	Understanding the roles of the EMT transcription factors in epigenetic remodelling and myeloid cell transformation.	$809,520
	Dr Justin Hamilton Australian Centre for Blood Diseases	Targeting a novel anti-platelet mechanism for improved anti-thrombotic therapy	$985,938
	A/Prof Margaret Hibbs Department of Immunology and Pathology	G-CSF: a pathogenic effector in chronic obstructive pulmonary disease and its comorbidities	$1,241,551
		Dissecting the contribution of IL-17-producing γδ T cells to the pathogenesis of airway diseases	$724,428
	A/Prof Benjamin Marsland Department of Immunology and Pathology	Clinical implications of trans-kingdom microbial interactions in the transplanted lung
	Prof Harshal Nandurkar Australian Centre for Blood Diseases	Targeted delivery of CD39 to the ischaemic brain improves outcomes in stroke.	$895,780
	Prof Anton Peleg Department of Infectious Diseases	Bacterial and Host Drivers of Fulminant Community-acquired Acinetobacter baumannii Infection	$729,315
		Antibiotic Resistance and Host Immune Evasion in Staphylococcus aureus	$644,428
	Prof Magdalena Plebanski Department of Immunology and Pathology	Vaccine Immunomodulation Throughout the Aging Lifespan (VITAL Study)	$795,117
	Prof Andrew Spencer Australian Centre for Blood Diseases	Analysis of circulating tumour DNA for mutational characterisation and tracking disease progression in multiple myeloma	$908,676
	Prof David Tarlinton Department of Immunology and Pathology	IL21, B-cell Proliferation and the Mechanism of Memory Formation	$968,340
	A/Prof Glen Westall Department of Allergy, Immunology and Respiratory medicine	Extending life after lung transplantation - defining the structural and immunological drivers of chronic lung allograft dysfunction	$739,190
	A/Prof Sandy Shultz Department of Neuroscience	Mild traumatic brain injuries and neurodegenerative disease	$928,690
	Prof Patrick Kwan Department of Neuroscience	Clinical utility and cost-effectiveness of genome sequencing for refractory epilepsy in children and adults: a multicentre randomised controlled trial	$720,609

More about the overall NHMRC figures:

• $640 million in National Health and Medical Research Council (NHMRC) funding will be invested by the Turnbull Government in world-leading health and medical research in the laboratory, clinic and community on a wide range of Australian health needs.
• Cancer research continues to be a priority for the Government.
• 732 health and medical research grants have been announced today covering 11 funding schemes and providing support for researchers in each state and territory.
• In 2017, its 80th year, NHMRC is providing more than $877 million in total funding for health and medical research.
• $109 million is being allocated to projects led by some of the brightest minds in Australia, searching for better cancer detection, treatments, care and cures.
• Over $96 million is being provided to research on cardiovascular disease—a disease that affects 4.2 million Australians
• Over $53 million will be targeted through research projects that aim to help the four million Australians who suffer from a form of mental illness each year.
• $31 million will be provided for research grants on Indigenous health issues. This is a continuing commitment of NHMRC to expend at least 5 per cent of MREA on Aboriginal and Torres Strait Islander research this year.
• The funding announced today builds on the $202 million of medical research funding announced by the Prime Minister in October and the allocation of $70 million through the Medical Research Future Fund Next Generation Clinical Researchers program announced in November.